ISP-Liability & Media Law
Client Alert | 2 min read | 02.04.10
Other sections of this issue:
Privacy & Data Protection | ISP-Liability & Media Law | Contracts & E-Commerce |
Electronic Communications & IT
In the Netherlands, the Council of Ministers decided to legally define the right of journalists to protect their sources.
Introduction
Although Dutch case law already recognized the right of journalists to protect their sources, the Dutch Council of Ministers decided to legally define this right. With this legal definition, the Council of Ministers aims at more clarity and certainty for journalists.
Who is concerned?
Only those persons that are professionally active in journalistic activities will benefit from the right to protect their sources. As such, the enactment would be more strict than the protection granted by case law. Before, the criterion to be professionally active was of no importance. It was sufficient to address yourself to a large audience and to act in the public interest to be granted the right to protect your sources.
Scope of the protection
The journalist will only obtain the right to protect his source if the data destined for disclosure to the public is communicated to the journalist in pursuance of his profession. Moreover, the right for the journalist to protect his source can also be limited for reasons of national security, territorial integrity or public safety, for the prevention of disorder or crime, for the protection of health or morals, etc.
Entry into force
The Council of Ministers agreed to have the State Council advice on the proposed act before introducing it with the Parliament for voting. Thus, there are still some steps to be taken before the right to protect sources is legally defined. Until that moment, it will be up to case law to judge whether or not journalists may protect their sources.
References: Press release from the Dutch government of 4 December 2009
Contacts
Insights
Client Alert | 4 min read | 04.18.24
Following federal lawmakers’ initiative to lower prescription drug prices under the Inflation Reduction Act of 2022, several states have taken similar steps to limit certain drugs’ prices. Drug affordability for consumers is a top priority for federal and state lawmakers and regulators because it is a bipartisan issue that directly impacts consumers’ wallets. With negotiations between the federal government and drug manufacturers over 10 drugs’ prices for Medicare beneficiaries well underway under the Inflation Reduction Act, 11 states, including Maryland and Colorado, have created drug affordability review boards to more directly tackle rising prices for both brand and generic drugs.[1] And another 12 states have pending legislation to create these boards.[2]
Client Alert | 6 min read | 04.16.24
Navigating the AI Intellectual Property Maze - Key Points From Congressional Hearing
Client Alert | 5 min read | 04.15.24
Making the EU Courts More Efficient for Trade-Related Decisions
Client Alert | 1 min read | 04.15.24
New FAR Part 40 to Address Supply Chain and Information Security Requirements
